Armata Pharmaceuticals

Yahoo Finance • last month

Armata Pharma earnings missed by $0.06, revenue topped estimates

Investing.com - Armata Pharma (NYSE: ARMP) reported second quarter EPS of $-0.450, $0.06 worse than the analyst estimate of $-0.390. Revenue for the quarter came in at $2.17M versus the consensus estimate of $1.38M. Armata Pharma’s stock... Full story

Yahoo Finance • 3 years ago

Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update

MARINA DEL REY, Calif., Aug. 11, 2022 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant... Full story

Yahoo Finance • 3 years ago

Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva

MARINA DEL REY, Calif., March 31, 2022 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant... Full story